CN114129630A - 一种安神助眠、恢复记忆的精油组合物制备方法及其应用 - Google Patents
一种安神助眠、恢复记忆的精油组合物制备方法及其应用 Download PDFInfo
- Publication number
- CN114129630A CN114129630A CN202111386774.9A CN202111386774A CN114129630A CN 114129630 A CN114129630 A CN 114129630A CN 202111386774 A CN202111386774 A CN 202111386774A CN 114129630 A CN114129630 A CN 114129630A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- parts
- sleep
- memory
- soothing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 151
- 210000005036 nerve Anatomy 0.000 title claims abstract description 68
- 230000007958 sleep Effects 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 240000000513 Santalum album Species 0.000 claims abstract description 21
- 235000008632 Santalum album Nutrition 0.000 claims abstract description 21
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 19
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 19
- 239000001102 lavandula vera Substances 0.000 claims abstract description 19
- 235000018219 lavender Nutrition 0.000 claims abstract description 19
- 241000218645 Cedrus Species 0.000 claims abstract description 13
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 13
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 13
- 235000002911 Salvia sclarea Nutrition 0.000 claims abstract description 13
- 244000182022 Salvia sclarea Species 0.000 claims abstract description 13
- 238000011084 recovery Methods 0.000 claims abstract description 13
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 12
- 240000003538 Chamaemelum nobile Species 0.000 claims abstract description 12
- 240000002505 Pogostemon cablin Species 0.000 claims abstract description 12
- 235000011751 Pogostemon cablin Nutrition 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 18
- 239000003755 preservative agent Substances 0.000 claims description 17
- 230000002335 preservative effect Effects 0.000 claims description 17
- 238000000222 aromatherapy Methods 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 13
- 229910021641 deionized water Inorganic materials 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 240000002319 Citrus sinensis Species 0.000 claims description 11
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 11
- 235000005979 Citrus limon Nutrition 0.000 claims description 9
- 244000131522 Citrus pyriformis Species 0.000 claims description 9
- 244000018436 Coriandrum sativum Species 0.000 claims description 9
- 235000002787 Coriandrum sativum Nutrition 0.000 claims description 9
- 244000270834 Myristica fragrans Species 0.000 claims description 9
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 9
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 9
- 244000223014 Syzygium aromaticum Species 0.000 claims description 9
- 239000001702 nutmeg Substances 0.000 claims description 9
- 235000002566 Capsicum Nutrition 0.000 claims description 8
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 8
- 239000006002 Pepper Substances 0.000 claims description 8
- 235000016761 Piper aduncum Nutrition 0.000 claims description 8
- 235000017804 Piper guineense Nutrition 0.000 claims description 8
- 235000008184 Piper nigrum Nutrition 0.000 claims description 8
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 8
- 239000004571 lime Substances 0.000 claims description 8
- 241000220317 Rosa Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 240000006909 Tilia x europaea Species 0.000 claims description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- 244000086363 Pterocarpus indicus Species 0.000 claims description 2
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 244000203593 Piper nigrum Species 0.000 claims 2
- 206010014970 Ephelides Diseases 0.000 abstract description 2
- 208000003351 Melanosis Diseases 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000003921 oil Substances 0.000 abstract description 2
- 238000007670 refining Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 235000002673 Dioscorea communis Nutrition 0.000 abstract 1
- 241000544230 Dioscorea communis Species 0.000 abstract 1
- 208000035753 Periorbital contusion Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 230000001914 calming effect Effects 0.000 description 8
- 230000008451 emotion Effects 0.000 description 8
- 230000036651 mood Effects 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 6
- 241000722363 Piper Species 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 208000019901 Anxiety disease Diseases 0.000 description 5
- 230000036506 anxiety Effects 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000013077 scoring method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000010877 cognitive disease Diseases 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000012547 Olfactory receptors Human genes 0.000 description 1
- 108050002069 Olfactory receptors Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001072961 Pogostemon Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000037413 effect on mental disease Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000003715 limbic system Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000000051 music therapy Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 210000003370 receptor cell Anatomy 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000036421 sense of balance Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
本发明专利公开了一种安神助眠、恢复记忆的精油组合物制备方法及其应用,所述精油组合物包括安神助眠组份和恢复记忆组份,所述安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊,所述恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香,本发明专利将安神助眠精油与恢复记忆精油组合为复合精油,在患者使用后能够提升记忆力,并且能够达到安神助眠的功效,为芳香疗法提供了较好的治疗契机,该精油组合物中含有薰衣草精油,该精油是由薰衣草提炼而成,可以清热解毒,清洁皮肤,控制油分,祛斑美白,祛皱嫩肤、祛除眼袋黑眼圈。
Description
技术领域
本发明专利涉及芳香疗法技术领域,具体为一种安神助眠、恢复记忆的精油组合物制备方法及其应用。
背景技术
对于抑郁症等情绪障碍及心理问题的干预措施,目前主要包括药物治疗和非药物干预两大类,药物治疗的副作用较大很多患者难以接受,在非药物干预中,心理学疗法由于需要专业的心理治疗师,治疗时间较长、费用昂贵等缺点导致患者接受度较低,应用效果不佳,音乐疗法和运动疗法也易受场地、设备、患者身体状况的多种因素的限制,因此未来有必要探索其他更简单、可行的干预方案。
芳香疗法主要通过按摩、沐浴和吸入从芳香的草药萃取的精油,刺激嗅觉受体细胞,然后传递到边缘系统产生积极作用,以减少心理疾病和增加幸福感,1928年,法国学者ReneMaurice首次提出“芳香疗法”的概念,即“Aromatherapie”,芳香植物种类丰富,可产生多种芳香物质,其形成方式多样,作用途径不尽相同,能够调节人体心理状态机制,具有见效迅速、效果持久、天然、安全、温和等优点,近些年,芳香疗法作为一种新兴干预方法,逐步应用于临床实践中,常用于抑郁症等精神疾病的辅助治疗,近期研究还证实,薰衣草精油对抑郁大鼠海马及杏仁核pCREB及c-fos等基因表达明显减弱,提示对该精油对抑郁症有明显改善作用,此外,芳香疗法对于老年人负性情绪的改善有着显著效果,据Cochrane协作网于2020年的系统评价显示,芳香方法能够有效改善老年人的睡眠障碍与抑郁情绪,多项研究显示,芳香疗法还对老年痴呆症患者的认知功能具有改善作用,能够促进记忆功能重建、减少认知障碍症状,并可应用于老年痴呆症的早期干预,除了老年人群,研究显示,芳香疗法能促进癌症患者身心康复,缓解其躯体症状,包括睡眠、情绪、恶心呕吐、疲乏、疼痛、水肿、便秘等,对癌症患者的心理问题,芳香疗法也能在一定程度上得以缓解,2020年的一项系统评价显示,芳香疗法作为一种补充替代疗法能有效缓解癌症患者的焦虑情绪,但现有证据并不能显示芳香降低癌症患者的抑郁水平,其长期效果仍需进一步研究及证实。
综上所述,芳香疗法的应用潜力大,对于抑郁症等精神疾病、老年人的认知障碍和负性情绪问题、癌症患者的负性情绪及躯体症状可能起到辅助治疗的效果,基于上述背景,市面上急需一种安神助眠、恢复记忆的精油组合物来辅助芳香疗法进行干预治疗。
发明专利内容
本发明专利的目的在于提供一种安神助眠、恢复记忆的精油组合物制备方法及其应用,为实现上述目的,本发明专利提供如下技术方案:一种安神助眠、恢复记忆的精油组合物,所述精油组合物包括安神助眠组份和恢复记忆组份。
优选的,所述安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊。
优选的,所述恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香。
优选的,所述安神助眠组份中各个精油的质量份数为:薰衣草8 份,雪松3份,苦橙叶5份,冷杉10份,檀香10份,快乐鼠尾草5 份,广藿香3份,罗马甘菊5份。
优选的,所述恢复记忆组份中各个精油的质量份数为:柠檬13份,甜橙4份,莱姆1份,丁香3份,芫荽1份,肉豆蔻3份,花椒5份,大马士革玫瑰3份,檀香10份。
优选的,所述安神助眠组份的质量份数为49份,所述恢复记忆组份的质量份数为43份。
优选的,所述精油组合物中还包含有防腐剂1份和去离子水7份,所述安神助眠组份,恢复记忆组份,防腐剂和去离子水的质量份数之和为100份。
优选的,所述防腐剂为苯氧乙醇和/或乙基己基甘油。
一种安神助眠、恢复记忆的精油组合物的制备方法,其制备方法包括如下步骤:
S1、安神助眠复合精油的制备,将安神助眠组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到安神助眠复合精油;
S2、恢复记忆复合精油的制备,将恢复记忆组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到恢复记忆复合精油;
S3、安神助眠、恢复记忆的精油组合物的制备,将安神助眠复合精油、恢复记忆复合精油、防腐剂和去离子水添加到搅拌器中充分搅拌即可得到安神助眠、恢复记忆的精油组合物。
同时本发明还公开了所述安神助眠、恢复记忆的精油组合物在芳香疗法精油中的应用。
与现有技术相比,本发明专利的有益效果如下:
本发明专利将安神助眠精油与恢复记忆精油组合为复合精油,在患者使用后能够提升记忆力,并且能够达到安神助眠的功效,为芳香疗法提供了较好的治疗契机,该精油组合物中含有薰衣草精油,该精油是由薰衣草提炼而成,可以清热解毒,清洁皮肤,控制油分,祛斑美白,祛皱嫩肤、祛除眼袋黑眼圈,还可促进受损组织再生恢复等护肤功能,薰衣草精油还对心脏有镇静效果,可降低高血压、安抚心悸,对于失眠很有帮助,雪松精油对消炎、抗菌、收敛、利尿、柔软、化痰和杀霉菌有很好的疗效,苦橙叶精油是神经系统的镇定剂,放松的特性,能帮助缓和失眠与心跳加快的焦虑感,能放慢身体的步调,调理呼吸,放松痉挛的肌肉,能安抚愤怒与恐慌,情绪低落时是好的抗忧郁剂,使心情焕然一新,舒缓情绪的效果比橙花要高,冷杉具有理气散寒的功效,檀香精油有放松、镇静的效果,解除精神紧张,带来祥和的气氛,令人增加充实感,放松全身等,特别适合在练瑜伽、冥想时使用,能够快速进入放松状态,快乐鼠尾草精油具有镇定紧张情绪,改善头疼和偏头痛,舒缓焦虑的心情,具有温暖,抗痉挛的特性,广藿香精油具有平衡、浪漫、和谐、情绪,强化中枢神经系统,平衡沮丧,提神,缓解紧张、焦虑情绪、消除疲劳、嗜睡、营造平衡感等有益功效,罗马甘菊精油发挥芳香物质所具有的生理和心理方面的作用,使人体的生理机能和心理平衡得以恢复。
本发明专利中的柠檬精油具有抚慰和缓解头疼和偏头疼的作用,通过综合身体内的酸性物质,对治疗关节炎和风湿病也有帮助,甜橙是少数被证明有镇静作用的精油之一,有着甜甜橙香味的甜橙精油,平缓神经,减压,保持身心愉悦,增进活力,可以驱离紧张情绪和压力、改善焦虑所引起的失眠,莱姆精油使人生气蓬勃,特别在你感觉不带劲、焦虑和沮丧时,让疲惫的心灵焕然一新,丁香精油能够舒缓因情绪郁结而产生的不快或胸闷感,芫荽精油能激励心情,特别是在嗜睡、疲累、紧张和神经衰弱时,肉豆蔻精油让心灵产生活力,也能让昏厥的感觉消散,回复清醒,大马士革玫瑰精油能抚慰和协调情绪,对抑郁、生气、悲痛、恐惧、神经紧张和压抑有帮助;同时,还能增加性欲、自身滋养、自信和处理情感问题的能力。
附图说明
为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1为本发明使用前A组问卷得分情况分布柱状图;
图2为本发明使用前B组问卷得分情况分布柱状图;
图3为本发明使用前不同区间人数在A组中所占比例饼状图;
图4为本发明使用前不同区间人数在B组中所占比例饼状图;
图5为本发明使用过程中A组问卷得分情况柱状图;
图6为本发明使用过程中B组问卷得分情况柱状图;
图7为本发明A组与B组实验对象心理状态变化过程折线图;
图8为本发明A组第一次问卷调查结果的饼状图;
图9为本发明A组第二次问卷调查结果的饼状图;
图10为本发明A组第三次问卷调查结果的饼状图;
图11为本发明A组第四次问卷调查结果的饼状图;
图12为本发明B组第一次问卷调查结果的饼状图;
图13为本发明B组第二次问卷调查结果的饼状图;
图14为本发明B组第三次问卷调查结果的饼状图;
图15为本发明B组第四次问卷调查结果的饼状图。
具体实施方式
下面将结合本发明专利中的实施例,对本发明专利实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明专利一部分实施例,而不是全部的实施例。基于本发明专利中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明专利保护的范围。
一种安神助眠、恢复记忆的精油组合物制备方法及其应用,一种安神助眠、恢复记忆的精油组合物,精油组合物包括安神助眠组份和恢复记忆组份,安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊,恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香,安神助眠组份中各个精油的质量份数为:薰衣草8份,雪松3份,苦橙叶5份,冷杉10份,檀香10份,快乐鼠尾草5份,广藿香3份,罗马甘菊5份,恢复记忆组份中各个精油的质量份数为:柠檬13份,甜橙4份,莱姆1份,丁香3份,芫荽1份,肉豆蔻3份,花椒5份,大马士革玫瑰3份,檀香10份,安神助眠组份的质量份数为49份,恢复记忆组份的质量份数为43份,精油组合物中还包含有防腐剂1份和去离子水7份,安神助眠组份,恢复记忆组份,防腐剂和去离子水的质量份数之和为100份,防腐剂为苯氧乙醇和/或乙基己基甘油;
一种安神助眠、恢复记忆的精油组合物的制备方法,其制备方法包括如下步骤:
S1、安神助眠复合精油的制备,将安神助眠组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到安神助眠复合精油;
S2、恢复记忆复合精油的制备,将恢复记忆组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到恢复记忆复合精油;
S3、安神助眠、恢复记忆的精油组合物的制备,将安神助眠复合精油、恢复记忆复合精油、防腐剂和去离子水添加到搅拌器中充分搅拌即可得到安神助眠、恢复记忆的精油组合物。
实施例一:
一种安神助眠、恢复记忆的精油组合物制备方法及其应用,一种安神助眠、恢复记忆的精油组合物,精油组合物包括安神助眠组份和恢复记忆组份,安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊,恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香;
一种安神助眠、恢复记忆的精油组合物的制备方法,其制备方法包括如下步骤:
S1、安神助眠复合精油的制备,将安神助眠组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到安神助眠复合精油;
S2、恢复记忆复合精油的制备,将恢复记忆组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到恢复记忆复合精油;
S3、安神助眠、恢复记忆的精油组合物的制备,将安神助眠复合精油、恢复记忆复合精油、防腐剂和去离子水添加到搅拌器中充分搅拌即可得到安神助眠、恢复记忆的精油组合物。
实施例二:
一种安神助眠、恢复记忆的精油组合物制备方法及其应用,一种安神助眠、恢复记忆的精油组合物,精油组合物包括安神助眠组份和恢复记忆组份,安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊,恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香,安神助眠组份中各个精油的质量份数为:薰衣草8份,雪松3份,苦橙叶5份,冷杉10份,檀香10份,快乐鼠尾草5份,广藿香3份,罗马甘菊5份,恢复记忆组份中各个精油的质量份数为:柠檬13份,甜橙4份,莱姆1份,丁香3份,芫荽1份,肉豆蔻3份,花椒5份,大马士革玫瑰3份,檀香10份;
一种安神助眠、恢复记忆的精油组合物的制备方法,其制备方法包括如下步骤:
S1、安神助眠复合精油的制备,将安神助眠组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到安神助眠复合精油;
S2、恢复记忆复合精油的制备,将恢复记忆组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到恢复记忆复合精油;
S3、安神助眠、恢复记忆的精油组合物的制备,将安神助眠复合精油、恢复记忆复合精油、防腐剂和去离子水添加到搅拌器中充分搅拌即可得到安神助眠、恢复记忆的精油组合物。
实施例三:
一种安神助眠、恢复记忆的精油组合物制备方法及其应用,一种安神助眠、恢复记忆的精油组合物,精油组合物包括安神助眠组份和恢复记忆组份,安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊,恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香,安神助眠组份中各个精油的质量份数为:薰衣草8份,雪松3份,苦橙叶5份,冷杉10份,檀香10份,快乐鼠尾草5份,广藿香3份,罗马甘菊5份,恢复记忆组份中各个精油的质量份数为:柠檬13份,甜橙4份,莱姆1份,丁香3份,芫荽1份,肉豆蔻3份,花椒5份,大马士革玫瑰3份,檀香10份,安神助眠组份的质量份数为49份,恢复记忆组份的质量份数为43份,精油组合物中还包含有防腐剂1份和去离子水7份,安神助眠组份,恢复记忆组份,防腐剂和去离子水的质量份数之和为100份,防腐剂为苯氧乙醇和/或乙基己基甘油;
一种安神助眠、恢复记忆的精油组合物的制备方法,其制备方法包括如下步骤:
S1、安神助眠复合精油的制备,将安神助眠组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到安神助眠复合精油;
S2、恢复记忆复合精油的制备,将恢复记忆组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到恢复记忆复合精油;
S3、安神助眠、恢复记忆的精油组合物的制备,将安神助眠复合精油、恢复记忆复合精油、防腐剂和去离子水添加到搅拌器中充分搅拌即可得到安神助眠、恢复记忆的精油组合物。
本发明还公开了安神助眠、恢复记忆的精油组合物在芳香疗法精油中的应用:
一、安神助眠、恢复记忆的精油组合物使用前的实验对象心理评估问卷结果:
在给实验对象使用安神助眠、恢复记忆的精油组合物前,我们选择了一套较为全面的心里评估问卷卷包含40道题目,问卷评分方法为:选择“从未发生”加3分,“偶尔发生”加2分,“经常发生”加1 分;“没有或很少时间”加3分,“小部分时间”加2分,“相当多时间”加1分“绝大部分时间或全部时间”不加分,则得分越低者初始心理状态越差,反之,得分越高者心理状态越好,根据评分方法及问卷的题目,认为若得分x≤70,则此实验对象的心理状态较为紧张,负面情绪需要缓解,根据问卷的评分方法,计算各问卷的得分,得分情况分布如图1和图2所示;
不同区间人数在本组中所占比例如图3和图4所示。
二、安神助眠、恢复记忆的精油组合物使用过程中的调查问卷结果:
在使用过程中的问卷为前一问卷的简化版,以避免实验对象同一份问卷而形成惯性,使结果不准,问卷评分标准为:“完全不符合“加 3分”“少部分符合”加2分,“大部分符合”加1分,“完全符合”不加分,则分数越高,负面情绪越少,反之分数越低,负面情绪越少,根据问卷的评分方法,计算各问卷的得分,得分情况分布如图5和图6 所示;
最终,综合这两份问卷的所有结果,将x≤70和x<27分为1档, 70<x≤80和27≤x<37分为2档,80<x≤90和37<x≤47分为3档, 90<x和47<x≤57分为4档,A组的1档变化线则标为A-1,以此类推,则可得出A组与B组的实验对象心理状态变化过程的折线图,如图7-图15所示。
结果分析:
根据评分标准分析,1档人数减少,4档人数增多是实验对象心理负面情绪减少的体现,根据数据和图表所示,可看出虽然第四次调查问卷显示A组中4档人数多于B组,但是在初始调查问卷中,B组人数就少于A组,且通过折线图可看出,A组4档人数呈减少趋势,B组4 档人数呈增多趋势,A组的1档与B组的1档起始人数相近,而最后一次调查显示B组中1档人数减为0,A组1档仍有3个人,由此推测, B组使用的安神助眠、恢复记忆的精油组合物是带有缓解负面情绪的,且在一个月内,安神助眠、恢复记忆的精油组合物即可发挥较好的效果。
尽管已经示出和描述了本发明专利的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明专利的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明专利的范围由所附权利要求及其等同物限定。
Claims (10)
1.一种安神助眠、恢复记忆的精油组合物,其特征在于:所述精油组合物包括安神助眠组份和恢复记忆组份。
2.根据权利要求1所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述安神助眠组份包括如下精油成分:薰衣草,雪松,苦橙叶,冷杉,檀香,快乐鼠尾草,广藿香,罗马甘菊。
3.根据权利要求1所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述恢复记忆组份包括如下精油成分:柠檬,甜橙,莱姆,丁香,芫荽,肉豆蔻,花椒,大马士革玫瑰,檀香。
4.根据权利要求1所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述安神助眠组份中各个精油的质量份数为:薰衣草8份,雪松3份,苦橙叶5份,冷杉10份,檀香10份,快乐鼠尾草5份,广藿香3份,罗马甘菊5份。
5.根据权利要求1所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述恢复记忆组份中各个精油的质量份数为:柠檬13份,甜橙4份,莱姆1份,丁香3份,芫荽1份,肉豆蔻3份,花椒5份,大马士革玫瑰3份,檀香10份。
6.根据权利要求1所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述安神助眠组份的质量份数为49份,所述恢复记忆组份的质量份数为43份。
7.根据权利要求1所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述精油组合物中还包含有防腐剂1份和去离子水7份,所述安神助眠组份,恢复记忆组份,防腐剂和去离子水的质量份数之和为100份。
8.根据权利要求7所述的一种安神助眠、恢复记忆的精油组合物,其特征在于:所述防腐剂为苯氧乙醇和/或乙基己基甘油。
9.根据权利要求1-8中任意一项所述的一种安神助眠、恢复记忆的精油组合物的制备方法,其特征在于:其制备方法包括如下步骤:
S1、安神助眠复合精油的制备,将安神助眠组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到安神助眠复合精油;
S2、恢复记忆复合精油的制备,将恢复记忆组份中的精油成分按照质量份数添加在搅拌器中充分搅拌得到恢复记忆复合精油;
S3、安神助眠、恢复记忆的精油组合物的制备,将安神助眠复合精油、恢复记忆复合精油、防腐剂和去离子水添加到搅拌器中充分搅拌即可得到安神助眠、恢复记忆的精油组合物。
10.根据权利要求1-8中任意一项所述的一种安神助眠、恢复记忆的精油组合物在芳香疗法精油中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111386774.9A CN114129630A (zh) | 2021-11-22 | 2021-11-22 | 一种安神助眠、恢复记忆的精油组合物制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111386774.9A CN114129630A (zh) | 2021-11-22 | 2021-11-22 | 一种安神助眠、恢复记忆的精油组合物制备方法及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114129630A true CN114129630A (zh) | 2022-03-04 |
Family
ID=80390731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111386774.9A Pending CN114129630A (zh) | 2021-11-22 | 2021-11-22 | 一种安神助眠、恢复记忆的精油组合物制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114129630A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115572640A (zh) * | 2022-10-22 | 2023-01-06 | 广州芬豪香精有限公司 | 一种助眠安神香精及其制备方法 |
CN116407591A (zh) * | 2023-03-28 | 2023-07-11 | 科丽思化妆品(上海)有限公司 | 一种助眠复方精油组合物、精油微胶囊及精油微胶囊的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104740011A (zh) * | 2015-04-03 | 2015-07-01 | 韩山师范学院 | 一种用于安神促眠的精油及其制备方法 |
CN107233412A (zh) * | 2017-05-27 | 2017-10-10 | 江西中医药大学 | 一种促进睡眠的复方精油组合物及其制备方法和用途 |
CN108635441A (zh) * | 2018-05-16 | 2018-10-12 | 北京斯利安药业有限公司 | 复方精油组合物、其应用以及改善睡眠的产品 |
-
2021
- 2021-11-22 CN CN202111386774.9A patent/CN114129630A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104740011A (zh) * | 2015-04-03 | 2015-07-01 | 韩山师范学院 | 一种用于安神促眠的精油及其制备方法 |
CN107233412A (zh) * | 2017-05-27 | 2017-10-10 | 江西中医药大学 | 一种促进睡眠的复方精油组合物及其制备方法和用途 |
CN108635441A (zh) * | 2018-05-16 | 2018-10-12 | 北京斯利安药业有限公司 | 复方精油组合物、其应用以及改善睡眠的产品 |
Non-Patent Citations (1)
Title |
---|
贡雪: "澳洲芳疗师"严谨分型"不怠慢", 《中国化妆品》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115572640A (zh) * | 2022-10-22 | 2023-01-06 | 广州芬豪香精有限公司 | 一种助眠安神香精及其制备方法 |
CN115572640B (zh) * | 2022-10-22 | 2023-12-19 | 广州芬豪香精有限公司 | 一种助眠安神香精及其制备方法 |
CN116407591A (zh) * | 2023-03-28 | 2023-07-11 | 科丽思化妆品(上海)有限公司 | 一种助眠复方精油组合物、精油微胶囊及精油微胶囊的制备方法 |
CN116407591B (zh) * | 2023-03-28 | 2024-04-05 | 科丽思化妆品(上海)有限公司 | 一种助眠复方精油组合物、精油微胶囊及精油微胶囊的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732458B (zh) | 一种提神醒脑抗疲劳的复方精油及含有该精油的湿纸巾 | |
CN114129630A (zh) | 一种安神助眠、恢复记忆的精油组合物制备方法及其应用 | |
Fradelos et al. | The use of essential oils as a complementary treatment for anxiety | |
CN104983927A (zh) | 一种应用于焦虑症康复理疗中静心宁神的复方精油 | |
CN104800430A (zh) | 一种改善睡眠深度的精油 | |
Stevensen | Nonpharmacological aspects of acute pain management | |
CN107412589A (zh) | 一种多功能助眠安神健脑药包 | |
Morita et al. | Case Report: Acupuncture is an effective treatment for olfactory dysfunction in the post COVID-19 condition | |
Cook et al. | Aromatherapy: reviewing evidence for its mechanisms of action and CNS effects | |
Bamford | A multifaceted approach to the treatment of phantom limb pain using hypnosis | |
Cho | Evidence-based non-pharmacological therapies for palliative cancer care | |
Waheed et al. | The Efficacy of Aroma and Music Therapy to Reduce Dental Anxiety and Pain Intensity | |
WH et al. | The use of traditional Malay massage and traditional Malay herbs in Malaysia: A review | |
Taylor et al. | Other nonpharmacological treatments of insomnia | |
Bamdad | The Long-Term Effects of Emotional Freedom Technique on Anxiety | |
Imanishi | Effect of Massage Therapy on Anxiety and Depression in Cancer Patients | |
Brown et al. | Advanced Integrative Therapy: Origins, Research, Theory, and Practice. | |
Karmani et al. | Traditional methods of stress management | |
CN106822614A (zh) | 一种用于治疗偏头痛的纯中药药物及使用方法 | |
Bobade et al. | A Review on Ayurved in the Treatment and Management of Motor Neuron Disease | |
Svoboda et al. | Case study: the effects of selected essential oils on mood, concentration and sleep in a group of 10 students monitored for 5 weeks | |
Alex | The Effect of Yoga on the Psychological Distress of Cancer Patients: An Analytical Study | |
OLTEAN et al. | SCIENTIFIC CONSIDERATIONS REGARDING THE RESEARCH METHODOLOGY IN CRANIOSACRAL THERAPY FOR CERVICAL PAIN. | |
Scholar | AYURVEDA ABHYANGA (MASSAGE) PROCEDURE-A REVIEW | |
Shetty et al. | Scalp Acupuncture on the Immediate and Prolonged Motor Recovery in Spinal Cord Injury: a Case Report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220304 |